UNIVERSAL IBOGAINE INCUNIVERSAL IBOGAINE INCUNIVERSAL IBOGAINE INC

UNIVERSAL IBOGAINE INC

No trades
See on Supercharts

IBO fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Universal Ibogaine, Inc. engages in developing ibogaine based drug franchise to treat addiction and related mental health issues. The company was founded by Shayne Nyquvest and Alberto Solá Agulló in 2018 and is headquartered in Calgary, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
IBO has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company